Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cochlear ( (AU:COH) ) has shared an update.
Cochlear Limited has announced the issuance of 791 ordinary fully paid securities, effective September 5, 2025. This move reflects the company’s ongoing efforts to manage its equity structure and potentially enhance its financial flexibility, which could impact its market positioning and stakeholder interests.
The most recent analyst rating on (AU:COH) stock is a Hold with a A$328.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited operates in the medical device industry, specializing in implantable hearing solutions. The company is a leader in providing cochlear implants and bone conduction systems, focusing on improving the quality of life for individuals with hearing loss.
Average Trading Volume: 169,175
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$19.61B
See more data about COH stock on TipRanks’ Stock Analysis page.